Lipitor MDL News: Zoll, Kranz & Borgess Notes The Lipitor MDL Is Sent to Judge Gergel in the Distric

The Firm is evaluating Lipitor lawsuits on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor. Toledo, Ohio (PRWEB) February 20, 2014 Federal Lipitor lawsuits are continuing to move forward in the U.S. District Court of South Carolina, Zoll Kranz & Borgess reports. On February 18, 2014, the Judicial Panel on Multidistrict Litigation (JPML) granted the renewed bid to centralize the Lipitor diabetes lawsuits. The lawsuits contend that the Plaintiffs developed type 2 diabetes as a result of taking Pfizer’s cholesterol-lowering drug. They further co
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations